Viewing Study NCT00613093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-02-24 @ 2:31 PM
Study NCT ID: NCT00613093
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme View
None Anaplastic Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Temodar View
None Temozolomide View
None O6-BG View
None O6-Benzylguanine View
None NSC 637037 View
None Temodar-Resistant Malignant Glioma View
None Brain tumor View
None CNS tumor View
None Cerebral glioblastoma View
None Anaplastic astrocytomas View
None Glioma View